Matthew R. Kane is CEO & President at PRECISION BIOSCIENCES INC (DTIL). They have made 10 open-market trades across 1 company since 2021, most recently 2021-05-13.
CIK 0001769887
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 10 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| DTIL | 2,013,597 | $11.6M |
Shares reported on the most recent Form 4, priced at the 2021-05-14 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DTIL | SELL | 2021-05-13 | 2021-05-14 | $8.96 | $173K | +15.5% | +23.9% | +25.4% |
| DTIL | SELL | 2021-05-07 | 2021-05-11 | $8.41 | $328K | +18.3% | +34.6% | +18.9% |
| DTIL | SELL | 2021-04-12 | 2021-04-14 | $8.67 | $169K | +12.0% | +7.7% | +23.2% |
| DTIL | SELL | 2021-04-08 | 2021-04-12 | $8.91 | $260K | +7.9% | +5.7% | +35.6% |
| DTIL | SELL | 2021-03-12 | 2021-03-16 | $11.36 | $221K | -9.0% | -18.4% | +5.9% |
| DTIL | SELL | 2021-03-10 | 2021-03-12 | $11.58 | $450K | -18.2% | -26.9% | +2.8% |
| DTIL | SELL | 2021-02-18 | 2021-02-22 | $12.23 | $237K | -0.5% | -15.6% | -6.1% |
| DTIL | SELL | 2021-02-16 | 2021-02-18 | $12.79 | $496K | +7.3% | -2.3% | -18.2% |
| DTIL | SELL | 2021-01-26 | 2021-01-28 | $13.37 | $259K | +20.0% | +5.7% | -18.6% |
| DTIL | SELL | 2021-01-22 | 2021-01-26 | $13.63 | $543K | +23.7% | -8.1% | -18.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.